WoundExpress

Advanced Wound Therapy Device

Clinical Evidence

The recent clinical study by Naik et al, 2019 has demonstrated that WoundExpress is highly effective in reducing the size of ‘hard to heal’ ulcers. In the 21 patient study, the average reduction in wound size was 44% with only 8 weeks of therapy. Most of these wounds were present for more than one year. 48% were of mixed aetiology and 52% were VLUs. 

The average VAS pain score also reduced from 34 to 15 with 5% of patients reducing their level of analgesics. 

Link:		Name:	Description:		File Name/Nos:
Consensus Document		Consensus Document	The Benefits of WoundExpress™		Consensus Document - The Benefits of WoundExpress
WoundExpress Clinical Paper		WoundExpress™ Clinical paper	Thigh-administered IPC for the treatment of lower limb ulcers		Thigh-administered IPC for the treatment of lower limb ulcers.pdf
WoundExpress White Paper		Chronic wound sites by  Morris et al	The use of intermittent pneumatic compression of the thigh with the WoundExpress™		785362 EN-2
WoundExpress Case Study		Case Studies	9 Clinical Evaluation Results		Issue 3
Making The Case		Making The Case	Wounds UK Advanced Wound Therapy Paper		Aug 2020
Wound Care Today Abstract		Conference Abstracts	Abstracts presented at Wound Care Today Conference		26-27 Feb 2020
Posters		Posters	Posters presented at Wound Care Today Conference		26-27 Feb 2020